Pharmaceutical News and Articles

Positive Data from Phase 2 CADENCE Trial Provides Definitive Proof-of-Concept for Winrevair (sotatercept-csrk) in Adults With the Syndrome of Combined Post- and Precapillary Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction

Merck (NYSE MRK), known as MSD outside of the United States and Canada, today announced detailed results from the Phase 2 CADENCE study, which was designed to e

Bristol Myers Squibb Presents Positive Results from Phase 3 SCOUT-HCM Trial Demonstrating Efficacy and Safety of Camzyos (mavacamten) in Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy

Bristol Myers Squibb (NYSE BMY) today announced positive data from the Phase 3 SCOUT-HCM trial of Camzyos (mavacamten), the first study of a cardiac myosin inhi

Novartis IgAN data in New England Journal of Medicine Show Fabhalta Slowed Kidney Function Decline by 49.3%

Basel, March 29, 2026 Novartis today announced final two-year results from the Phase III APPLAUSE IgAN study of Fabhalta (iptacopan) in IgA nephropathy (IgAN).

FDA Approves Awiqli (insulin icodec-abae) as the First and Only Once-Weekly Basal Insulin Treatment for Adults with Type 2 Diabetes

FDA Grants Accelerated Approval for Kresladi for the Treatment of Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)

ARS Pharmaceuticals Receives FDA Approval to Remove Age Requirement From neffy 1 mg (epinephrine nasal spray) Label

Study Links High Antioxidant Intake To Changes in Offspring Development

SUNDAY, March 29, 2026 Antioxidants are often seen as a good, simple way to boost health, but taking too many may come with some risks, new research suggests.A

Healthy Lab Results May Mask Future Risks for Kids with Obesity

FRIDAY, March 27, 2026 For parents of a child with obesity, a normal lab report from the pediatrician may suggest that their weight isn t yet a problem. But eve

Family Caregivers Provide $1 Trillion In Annual Labor, AARP Says

FRIDAY, March 27, 2026 Family caregivers provide more than 1 trillion in labor every year in the U.S., most of it unpaid, a new AARP report says. Their work for

New COVID 'Cicada' Variant Is Spreading — What Experts Want You To Know

FRIDAY, March 27, 2026 Another new COVID variant is starting to spread. Health officials say the variant known as BA.3.2 or Cicada has been quietly circulating